Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4cry | ACO | PanD regulatory factor |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4cry | ACO | PanD regulatory factor | / | 1.000 | |
4cs0 | ACO | PanD regulatory factor | / | 0.631 | |
4crz | ACO | PanD regulatory factor | / | 0.601 | |
4ag7 | COA | Glucosamine 6-phosphate N-acetyltransferase | / | 0.537 | |
4hkf | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.530 | |
1n71 | COA | Aac(6')-Ii protein | / | 0.527 | |
2wpw | ACO | Orf14 | / | 0.513 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.511 | |
2wpx | ACO | Orf14 | / | 0.508 | |
4b5o | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.506 | |
1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.505 | |
3vwd | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.502 | |
4ajw | VWN | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 2.7.1.153 | 0.498 | |
3f0a | ACO | Spermidine N(1)-acetyltransferase | / | 0.497 | |
2ob0 | ACO | N-alpha-acetyltransferase 50 | / | 0.494 | |
2cy2 | ACO | Probable acetyltransferase | / | 0.492 | |
4u9z | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.492 | |
4gs4 | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.490 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.489 | |
3vwe | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.484 | |
3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.482 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.482 | |
2a4n | COA | Aac(6')-Ii protein | / | 0.481 | |
2wuf | KEM | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.481 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.475 | |
1p0h | ACO | Mycothiol acetyltransferase | 2.3.1.189 | 0.474 | |
4jv6 | 18F | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.474 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.470 | |
4u9v | ACO | N-alpha-acetyltransferase 40 | 2.3.1 | 0.470 | |
5kf2 | COA | Predicted acetyltransferase | / | 0.469 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.468 | |
4h6z | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.468 | |
4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.468 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
1b87 | ACO | Aac(6')-Ii protein | / | 0.466 | |
2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.466 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
4b5p | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.466 | |
4u9y | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.466 | |
1daj | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.465 | |
2c27 | ACO | Mycothiol acetyltransferase | 2.3.1.189 | 0.465 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.462 | |
1jtu | LYB | Thymidylate synthase | / | 0.461 | |
4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.461 | |
2a4z | BYM | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
4g1y | 0VO | Vitamin D3 receptor A | / | 0.460 | |
4if5 | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.460 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.460 | |
1e8x | ATP | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
2blc | CP7 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.459 | |
3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.459 | |
1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
1jut | LYD | Thymidylate synthase | / | 0.458 | |
1mb9 | ATP | Carboxyethyl-arginine beta-lactam-synthase | 6.3.3.4 | 0.458 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2bbq | PFG | Thymidylate synthase | / | 0.458 | |
3um6 | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.458 | |
5kgp | ACO | Predicted acetyltransferase | / | 0.458 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
3bgx | MEF | Thymidylate synthase | / | 0.457 | |
1f28 | UMP | Thymidylate synthase | 2.1.1.45 | 0.456 | |
3ls8 | AJZ | Phosphatidylinositol 3-kinase catalytic subunit type 3 | 2.7.1.137 | 0.456 | |
4l23 | X6K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.455 | |
1zpr | CB3 | Thymidylate synthase | / | 0.454 | |
3c3d | FO1 | 2-phospho-L-lactate transferase | / | 0.454 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.454 | |
1ewy | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.453 | |
1kgj | FL8 | Transthyretin | / | 0.453 | |
4eqr | FAD | Coenzyme A disulfide reductase | / | 0.453 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.453 | |
2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.452 | |
3f8k | COA | Uncharacterized protein | / | 0.452 | |
3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.452 | |
4jqh | 1MF | Alr2278 protein | / | 0.452 | |
5kgh | ACO | Predicted acetyltransferase | / | 0.452 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
2x7b | COA | N-alpha-acetyltransferase | 2.3.1 | 0.451 | |
3slk | NDP | Polyketide synthase extender module 2 | / | 0.451 | |
4h6u | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.451 | |
1juj | LYA | Thymidylate synthase | 2.1.1.45 | 0.450 | |
2hcd | BIV | Vitamin D3 receptor A | / | 0.450 | |
2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.450 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.450 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.450 | |
1vj3 | TAB | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
2fzi | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2psw | COA | N-alpha-acetyltransferase 50 | / | 0.449 | |
2wue | KEK | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.449 | |
3c1x | CKK | Hepatocyte growth factor receptor | 2.7.10.1 | 0.449 | |
4h98 | 14Q | Uncharacterized protein | / | 0.449 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.449 | |
1dgm | ADN | Adenosine kinase | 2.7.1.20 | 0.448 | |
1f28 | F89 | Thymidylate synthase | 2.1.1.45 | 0.448 | |
1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.448 | |
2wug | HPK | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.448 | |
3amy | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
1cg6 | MTA | S-methyl-5'-thioadenosine phosphorylase | / | 0.447 | |
1d3h | A26 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.447 | |
2a5u | QYT | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.447 | |
3u8d | U8D | Phospholipase A2, membrane associated | / | 0.447 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.447 | |
4ocv | ANP | Aminoglycoside phosphotransferase | / | 0.447 | |
5kf2 | ACO | Predicted acetyltransferase | / | 0.447 | |
3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.446 | |
3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.446 | |
4fa6 | 0TA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
4g21 | 0VP | Vitamin D3 receptor A | / | 0.446 | |
4h97 | 53S | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
4kxn | 6K6 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | / | 0.446 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.446 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.446 | |
4nmb | FAD | Bifunctional protein PutA | / | 0.446 | |
5ckw | ANP | Uncharacterized protein | / | 0.446 | |
1n4h | REA | Nuclear receptor ROR-beta | / | 0.445 | |
3b9l | AZZ | Serum albumin | / | 0.445 | |
3wsb | RWZ | Farnesyltransferase, putative | / | 0.445 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.445 | |
2bfp | H4B | Pteridine reductase 1 | 1.5.1.33 | 0.444 | |
3jwc | EKB | Dihydrofolate reductase | / | 0.444 | |
3zp4 | TSA | Chorismate mutase AroH | 5.4.99.5 | 0.444 | |
1syn | F89 | Thymidylate synthase | / | 0.443 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
2bxq | IMN | Serum albumin | / | 0.443 | |
2gjn | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.443 | |
2tps | TPS | Thiamine-phosphate synthase | / | 0.443 | |
3c3e | GDP | 2-phospho-L-lactate transferase | / | 0.443 | |
3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.443 | |
3up0 | D7S | aceDAF-12 | / | 0.443 | |
3upy | FOM | Oxidoreductase, putative | / | 0.443 | |
3vru | YS3 | Vitamin D3 receptor | / | 0.443 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.443 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.443 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.443 | |
4pd6 | URI | Nucleoside permease | / | 0.443 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
2z3u | CRR | Cytochrome P450 | / | 0.442 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.442 | |
3vt9 | YI4 | Vitamin D3 receptor | / | 0.442 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4cav | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.442 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.442 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.441 | |
1iyz | NDP | Probable quinone oxidoreductase | / | 0.441 | |
1kzj | CB3 | Thymidylate synthase | / | 0.441 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
1rf7 | DHF | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1sd1 | FMC | S-methyl-5'-thioadenosine phosphorylase | / | 0.441 | |
2fto | CB3 | Thymidylate synthase | / | 0.441 | |
3koo | 24D | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.441 | |
4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
1q4u | 4CA | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.440 | |
3bqd | DAY | Glucocorticoid receptor | / | 0.440 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.440 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.440 | |
3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.440 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.440 | |
3w5t | LHP | Vitamin D3 receptor | / | 0.440 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.440 | |
4j26 | EST | Estrogen receptor beta | / | 0.440 | |
4qys | PLR | Tryptophan synthase beta chain 2 | 4.2.1.20 | 0.440 |